Protein kinases are major signaling molecules that are involved in a variety of cellular processes. However, the molecular mechanisms whereby protein kinases discriminate specific substrates are still largely unknown. Ca 2+ -dependent protein kinases (CDPKs) play central roles in Ca 2+ signaling in plants. Previously, we found that a tobacco (Nicotiana tabacum) CDPK1 negatively regulated the transcription factor REPRESSION OF SHOOT GROWTH (RSG), which is involved in gibberellin feedback regulation. Here, we found that the variable N-terminal domain of CDPK1 is necessary for the recognition of RSG. A mutation (R10A) in the variable N-terminal domain of CDPK1 reduced both RSG binding and RSG phosphorylation while leaving kinase activity intact. Furthermore, the R10A mutation suppressed the in vivo function of CDPK1. The substitution of the variable N-terminal domain of an Arabidopsis thaliana CDPK, At CPK9, with that of Nt CDPK1 conferred RSG kinase activities. This chimeric CDPK behaved according to the identity of the variable N-terminal domain in transgenic plants. Our results open the possibility of engineering the substrate specificity of CDPK by manipulation of the variable N-terminal domain, enabling a rational rewiring of cellular signaling pathways.
INTRODUCTION
Protein phosphorylation is the most widespread posttranslational modification used in cells. Protein kinases regulate many basic cellular processes, including gene expression, metabolism, cell division, differentiation, membrane transport, and growth. Genome sequencing has revealed that most multicellular organisms contain large expansions of a relatively small number of protein kinases. For example, both Arabidopsis thaliana and rice (Oryza sativa) genomes contain large gene families of mitogen-activated protein kinases (MAPKs), receptorlike kinases, and Ca 2+ -dependent protein kinases (CDPKs) (Krupa et al., 2006) . These expansions have enabled organisms to rapidly diversify their information-processing capabilities against a variety of environmental stimuli without having to invent new signaling mechanisms. However, the expansion of a family of protein kinases raises a critical question, namely, how structurally related kinases recognize their specific target substrate among many potentially phosphorylatable proteins to avoid unwanted crosstalk.
The primary means of ensuring kinase specificity is believed to depend on the molecular recognition of substrates by catalytic domains. Protein kinases can be separated into two main groups: Ser/Thr-specific kinases and Tyr-specific kinases. Although these kinase groups phosphorylate different residues, they have similar structures in the catalytic domain (Huse and Kuriyan, 2002; Nolen et al., 2004) . Classical protein kinases have a canonical catalytic domain of 250 amino acids in length, which consists of a small N-terminal lobe of b-sheets and a larger C-terminal lobe of a-helices (Ubersax and Ferrell, 2007) . The protein substrate binds along the cleft between the two lobes and a set of conserved residues within the catalytic domain catalyze the transfer of the phosphate of ATP to the Ser, Thr, or Tyr residue of the substrate. Although all classical protein kinases share a common fold in the catalytic domains, they differ in terms of the charge and hydrophobicity of the surface residues (Brown et al., 1999) . A detailed understanding of specific kinasesubstrate interaction would make it possible to redesign cellular signal pathways through manipulation of the substrate specificity of kinases and would ultimately open the way to engineer new functions and modulate cellular behavior in a predictable manner. However, identifying the amino acids responsible for such substrate recognition is difficult at present. Site-directed mutagenesis could identify residues that are important for kinasesubstrate interaction, but this approach may not discriminate between the residues that are necessary for the catalytic reaction and those determining substrate specificity. A useful model system in which substrate recognition is separable from catalytic activity is required to facilitate the reprogramming of the kinasesubstrate relationship.
REPRESSION OF SHOOT GROWTH (RSG) is a tobacco (Nicotiana tabacum) transcriptional activator with a basic leucine zipper domain that regulates the transcription of gibberellin (GA) biosynthetic genes (Fukazawa et al., 2000) . The function of RSG is negatively regulated by 14-3-3 signaling proteins (Igarashi et al., 2001) , which form a highly conserved family of homo-and heterodimeric proteins in eukaryotes (for reviews, see van Hemert et al., 2001; Tzivion and Avruch, 2002) . The 14-3-3 proteins bind to RSG depending on the phosphorylation state of Ser-114 in RSG and thereby sequester RSG in the cytoplasm, rendering it unable to regulate its target genes in the nucleus (Igarashi et al., 2001; Ishida et al., 2004) . We found that GA levels regulate the intracellular localization of RSG; that is, RSG is translocated into the nucleus in response to a reduction in GA levels, and GA treatment could reverse this nuclear accumulation (Ishida et al., 2004) . RSG plays a role in the homeostasis of GAs through direct binding to the promoter of GA20ox1 encoding a GA 20-oxidase (Fukazawa et al., 2010) . The GA-dependent cytoplasmic migration of RSG requires 14-3-3 binding and Ser/ Thr kinase activity (Ishida et al., 2004) . We identified a CDPK, tobacco CDPK1, as an RSG kinase that promotes 14-3-3 binding of RSG by phosphorylation of Ser-114 in RSG (Ishida et al., 2008) . CDPK1 interacts with RSG in a Ca 2+ -dependent manner in vivo and in vitro and specifically phosphorylates Ser-114 in RSG in response to GAs. CDPK1 decodes the Ca 2+ signal produced by GAs and regulates the intracellular localization of RSG.
Ca 2+ is a ubiquitous second messenger that is involved in the signal transduction of many environmental and developmental stimuli in eukaryotes (Sanders et al., 2002; Schuster et al., 2002) . Among Ca 2+ binding sensory proteins in plants, CDPKs are thought to play central roles in Ca 2+ signaling because protein kinase C and conventional calmodulin-dependent protein kinase (CaMK), which represent the two major types of Ca 2+ -regulated kinases in animal systems, are missing from Arabidopsis (Hrabak et al., 2003) . CDPKs are Ser/Thr protein kinases that are only found in plants and some protozoans and are absent from the genomes of yeasts and animals. There are 34 genes encoding CDPKs in Arabidopsis (Arabidopsis Genome Initiative, 2000) and 29 genes in rice (Asano et al., 2005) . CDPK proteins are composed of a variable N-terminal domain, a kinase domain, an autoinhibitory domain, and a calmodulin-like domain (Hrabak et al., 2003) . While none of the CDPKs appear to be an integral membrane proteins, 24 of the 34 Arabidopsis CDPKs have potential N-myristoylation motifs for membrane association in the beginning of their highly variable N-terminal domain. They are activated upon binding Ca 2+ to their calmodulin-like domain, which makes them effective switches for the transduction of Ca 2+ signals in plant cells. CDPKs have been reported to be involved in diverse physiological processes, including the accumulation of storage starch and protein in immature seeds of rice (Asano et al., 2002) , tolerance to cold, salt, and drought stress in rice (Saijo et al., 2000) , a defense response in tobacco (Romeis et al., 2001) , root development and regulation of nodule number in Medicago truncatula (Ivashuta et al., 2005) , abscisic acid response in Arabidopsis (Choi et al., 2005) , and pollen tube growth in petunia (Petunia hybrida; Yoon et al., 2006) .
Because the primary structures of CDPK isoforms are very similar, as nearly 100% identity is found in the region surrounding the active site among Arabidopsis CDPKs, it was considered unlikely that they would have distinguishable substrate specificities. However, selective knockdown of CDPK1 caused a marked reduction in the RSG kinase activity in tobacco plants, indicating a distinct physiological function of CDPK1 in tobacco plants (Ishida et al., 2008) . A particularly interesting question arises, namely, how the transcription factor RSG is specifically recognized by CDPK1. In this study, we found that the variable N-terminal domain of CDPK1 is necessary for the recognition of RSG. The variable N-terminal domain of CDPK1 conferred RSG kinase activities to a distinct CDPK that does not recognize RSG. Our results open the possibility of engineering the substrate specificity of CDPK by manipulation of the variable N-terminal domain, which would provide an approach for the rewiring the signaling pathway.
RESULTS
The Variable N-Terminal Domain of CDPK1 Is Required for Binding to RSG CDPK1 binds to RSG in a Ca 2+ -dependent manner (Ishida et al., 2008) . To determine which region of CDPK1 is important for interaction with RSG, we constructed various deletion mutants of CDPK1 ( Figure 1A ) and performed an in vitro pull-down assay. Recombinant glutathione S-transferase (GST)-CDPK1 was absorbed to glutathione beads. The immobilized GST fusion protein was incubated with maltose binding protein (MBP)-full-length RSG followed by affinity chromatography. As shown in Figure 1B , full-length CDPK1 bound to RSG. Deletion of the calmodulin-like domain did not affect RSG binding ( Figure 1B, 1-357 ). On the other hand, deletion of the variable N-terminal domain abolished RSG binding (DVDCDPK1, . Furthermore, the binding ability of the variable N-terminal domain of CDPK1 (1-78) to RSG was comparable to that of full-length CDPK1. Although full-length CDPK1 bound to RSG in a Ca 2+ -dependent manner, the binding of N-terminal domain of CDPK1 (1 to 78) to RSG did not require calcium (see Supplemental Figure 1 online). Neither the kinase domain (79-357) nor the calmodulin-like domain with the autoinhibitory domain (358-542) bound to RSG. These results indicated that the variable N-terminal domain of CDPK1 is essential for binding to RSG in vitro. Although the functional importance of the variable N-terminal domain of CDPK had been unclear thus far, we found that it may be involved in substrate recognition.
Bimolecular fluorescence complementation (BiFC) assays (Hu et al., 2002) were used to examine the role of the variable N-terminal domain of CDPK1 in the interaction between CDPK1 and RSG in plant cells. To this end, either the wild-type CDPK1 or the DVDCDPK1 lacking the variable N-terminal domain was translationally fused to the N-terminal portion of a yellow fluorescent protein (YFP N ), which generated the YFP N -CDPK1 or the YFP N -DVDCDPK1 fusion protein, respectively. For the other partner, RSG was translationally fused to the C-terminal portion of a yellow fluorescent protein (YFP C ), which generated an RSG-YFP C fusion protein. The corresponding constructs were codelivered into leaf cells of tobacco by particle bombardment. The reconstituted YFP signal, caused by interaction between YFP N -CDPK1 and RSG-YFP C , was observed in leaf epidermal cells; however, no YFP signal was observed when YFP N -DVDCDPK1 was codelivered with RSG-YFP C ( Figure 1C ). Control experiments in which YFP N -CDPK1 or RSG-YFP C was coexpressed with unfused YFP C or unfused YFP N did not show any fluorescence. These results showed that the variable N-terminal domain of CDPK1 is necessary for the interaction between CDPK1 and RSG in living cells.
To examine the effect of the deletion of the variable N-terminal domain of CDPK1 on its kinase activity toward full-length RSG, we performed an in vitro kinase assay using antibodies that specifically recognize phosphor-Ser-114 of RSG (Ishida et al., 2004) . The deletion of the variable N-terminal domain of CDPK1 markedly reduced Ser-114 kinase activities when full-length RSG was used as a substrate ( Figure 1D , top panel). To confirm that DVDCDPK1 maintains the kinase activity itself, we used casein, a conventional substrate of Ser/Thr kinase. The peptide containing the phosphorylation site of the substrates is often Alteration of Substrate Specificity 3 of 13 used in phosphorylation assays (Wang et al., 2002) . We also used the peptide of the phosphorylation domain of RSG (70-140), which does not bind to the variable N-terminal domain of CDPK1. Because DVDCDPK1 phosphorylated both casein and the peptide of the phosphorylation domain of RSG comparably to wildtype CDPK1, deletion of the variable N-terminal domain did not affect the kinase activity ( Figure 1D ). These results suggested that both RSG binding and kinase activity on the full-length RSG of CDPK1 are dependent on the variable N-terminal domain of CDPK1 and that the substrate recognition of CDPK1 can be separated from the catalytic activity.
Arg-10 of CDPK1 Is Important for RSG Binding in Vitro and in Vivo
To further analyze the RSG binding domain within the variable N-terminal domain of CDPK1, we prepared GST fusions of two truncated forms of the variable N-terminal domain ( Figure 2A ) Figure  2B ). These results indicate that the RSG binding of CDPK1 is exclusively dependent on its 29 N-terminal amino acids.
To determine which amino acids of CDPK1 are important for RSG binding, we performed site-directed mutagenesis of the variable N-terminal domain ( Figure 2A ). Gly-2 and Cys-4 are potential N-myristoylation and palmitoylation sites, respectively, which might be involved in the membrane association of CDPK1. The N-terminal region of CDPK1 contains many Arg residues (i.e., 4 out of 29), which is characteristic among CDPKs. We then constructed mutant versions of CDPK1 in which these amino acids of the variable N-terminal domain were replaced with Ala ( Figure 2A ). Pull-down assays showed that the mutations of G2A and C4A did not affect the RSG binding, while the R10A mutation abolished it ( Figure 2C ). Mutation of R19A and double mutation of R22/23A reduced the binding ability to RSG. These results indicated that the Arg residues of the N terminus of CDPK1, especially Arg-10, are important for the interaction with RSG in vitro.
To confirm the importance of Arg-10 of CDPK1 for RSG binding in vivo, we generated transgenic tobacco plants overexpressing RSG-green fluorescent protein (GFP) with wild-type CDPK1 or the mutant CDPK1(R10A). Immunoprecipitation with anti-RSG antibodies showed that the R10A mutation reduced the association of RSG-GFP with CDPK1 in vivo ( Figure 2D ). These results demonstrated that Arg-10 of CDPK1 is important for RSG binding in vitro and in vivo.
R10A Mutation of CDPK1 Reduced the RSG Kinase Activities
To examine the influence of the R10A mutation of CDPK1 on its kinase activity toward full-length RSG, we performed an in vitro kinase assay using antibodies that specifically recognize phosphor-Ser-114 of RSG. The R10A mutation in CDPK1 markedly reduced Ser-114 kinase activities in the kinase assay using fulllength RSG as a substrate ( Figure 3A ). This mutation did not affect the kinase activity itself because the R10A mutant version of CDPK1 phosphorylated a control substrate, the phosphorylation domain of RSG, comparably to wild-type CDPK1. These results indicated that the R10A mutation in the variable N-terminal domain of CDPK1 affects RSG kinase activity of CDPK1 as well as its RSG binding.
To confirm the functional significance of Arg-10 of CDPK1 in plant cells, we used transgenic tobacco plants overexpressing the R10A mutant version of CDPK1. The kinase activity for Ser-114 of RSG in leaf cell extracts of the transgenic plants was examined by an in vitro kinase assay using antibodies that specifically recognize phosphor-Ser-114 of RSG. Similar to the results with recombinant CDPK1 produced in Escherichia coli ( Figure 3A ), R10A mutation in CDPK1 markedly reduced RSG kinase activities that phosphorylate Ser-114 of full-length RSG while leaving kinase catalytic activity intact ( Figure 3B , middle panel). These results suggest that Arg-10 in the variable N-terminal domain of CDPK1 is important for substrate recognition.
R10A Mutation Affects the in Vivo Function of CDPK1
It has been shown that GA biosynthesis is affected by the activity of the GA response pathway through a feedback mechanism (Hedden and Phillips, 2000) . Previously, we found that RSG and CDPK1 are involved in the feedback regulation of a GA 20-oxidase gene GA20ox1 (Ishida et al., 2008; Fukazawa et al., 2010) . Overexpression of CDPK1 inhibited the feedback regulation of GA20ox1 and resulted in the sensitization of germination to a GA biosynthetic inhibitor, Uniconazole P (Ishida et al., 2008) , because CDPK1 negatively regulates RSG by promoting 14-3-3 binding to RSG. If Arg-10 in the variable N-terminal domain of CDPK1 is functionally important in plants, the R10A mutation should suppress both the inhibitory effect on the feedback regulation of GA20ox1 and sensitization to Uniconazole P by CDPK1 overexpression. To test this, we used transgenic tobacco plants overexpressing the R10A mutant version of CDPK1.
As shown in Figure 4A , upregulation of GA20ox1 in response to Uniconazole P was inhibited by the overexpression of CDPK1 in the transgenic plants; however, as expected, the upregulation of GA20ox1 was not inhibited by overexpression of the R10A mutant version. It is noteworthy that the R10A mutation did not affect the kinase activity itself ( Figure 3 ). Next, we examined the germination ratio to know the effect of the R10A mutation of CDPK1 on the sensitivity to Uniconazole P. Although the CDPK1 overexpressor was more sensitive to Uniconazole P than control wild-type SR1 tobacco plants, the sensitivity to Uniconazole P of the R10A overexpressor was indistinguishable from that of control SR1 plants ( Figure 4B ). Treatment with GA 3 reversed the inhibition of germination. These results showed the functional importance of Arg-10 of CDPK1 in vivo, suggesting that CDPK1 recognizes the physiological substrate RSG by its variable N-terminal domain in plants.
Alteration of the Substrate Specificity by Manipulation of the Variable N-Terminal Domain
The redesign of the substrate specificity of kinases is a major challenge of protein engineering (Benner and Sismour, 2005) . To facilitate this, a model system in which substrate recognition is separable from catalytic activity is required. Our finding that substrate recognition of CDPK1 is determined by the variable N-terminal domain raises the possibility of altering the substrate specificity of a CDPK without affecting the kinase activities. To test whether the variable N-terminal domain of CDPK1 confers specificity for RSG to an Arabidopsis CDPK CPK9, we constructed a chimeric CDPK in which the variable N-terminal domain of At CPK9 was substituted with that of Nt CDPK1 ( Figure 5A ). Although the similarity between Nt CDPK1 and At CPK9 is only 34% in the variable N-terminal domain, that in other regions is 91%. At CPK9 neither bound nor phosphorylated fulllength RSG, although it has kinase activity ( Figures 5B and 5C ). Both the RSG binding ability and the kinase activity on the fulllength RSG of the chimeric CDPK were comparable with those of wild-type CDPK1 in a pull-down assay ( Figure 5B ) and in an in vitro kinase assay ( Figure 5C ). These results indicated that the chimeric CDPK behaved according to the identity of the variable N-terminal domain.
To examine the function of the chimeric CDPK in plants, we generated transgenic tobacco plants overexpressing At CPK9 or the chimeric CDPK, which was tagged with tandem affinity purification (TAP) tag at its C terminus. The RSG kinase activities in leaf cell extracts of the transgenic plants were examined by an in vitro kinase assay using antibodies that specifically recognize phosphor-Ser-114 of RSG. Similarly to the results with recombinant proteins produced in E. coli ( Figure 5C ), the variable N-terminal domain of Nt CDPK1 conferred RSG kinase activity to At CPK9 ( Figure 5D ). Next, we examined whether the chimeric CDPK suppresses the feedback regulation of GA20ox1 similarly to Nt CDPK1. Upregulation of GA20ox1 in response to a GA biosynthetic inhibitor, Uniconazole P, was suppressed by the overexpression of the chimeric CDPK in the transgenic plants ( Figure 5E ) as well as by that of Nt CDPK1 ( Figure 4A ). Overexpression of At CPK9 had no effect on the upregulation of GA20ox1. Finally, we examined whether the chimeric CDPK affects the sensitivity to Uniconazole P by measuring the germination ratio. As expected, the chimeric CDPK overexpressor was more sensitive to Uniconazole P than the At CPK9 overexpressor and control wild-type SR1 tobacco plants ( Figure 5E ). Thus, the function of the chimeric CDPK in vivo is indistinguishable from that of CDPK1. Collectively, our results suggested that the alteration of the substrate specificity of CDPK is possible by manipulation of the variable N-terminal domain.
DISCUSSION
Through the life cycle of multicellular organisms, cells respond to extracellular cues through nonlinear signal transduction cascades whose principal components have been identified. Nevertheless, the molecular mechanisms underlying the specificity of cellular responses are still largely unknown. Signaling components, such as kinases, often possess various potential substrates, leading to highly branched signaling networks rather than linear cascades. Cells use a variety of mechanisms to enforce the specificity of related, but distinct, signaling pathways (Schwartz and Madhani, 2004; Ubersax and Ferrell, 2007) .
The first level of substrate specificity arises from the interaction between the active site of the kinase and the amino acid sequences surrounding the phosphorylation site of the substrate. Consensus phosphorylation sites have been determined for several protein kinases, including CDPK (Harper and Harmon, 2005; Olsen et al., 2006) . Additional conserved docking motifs on the substrate that interacts with specific regions of the kinase domain may increase the selectivity of the kinase substrate (Sharrocks et al., 2000) . However, because the sequences of phosphorylation sites and docking motifs are rather simple and ambiguous, they are insufficient to account for the substrate specificity. For example, yeast cyclin-dependent kinase-1 (Cdk1) or yeast casein kinase 2 (YCK2) phosphorylated hundreds of proteins among thousands of yeast total proteins in vitro (Ubersax et al., 2003; Ptacek et al., 2005) . Other molecular mechanisms are required to select the functional targets among potential phosphorylation sites.
In addition to protein-protein interaction near the active site, spatial separation, namely, subcellular localization and tissuespecific expression, can help to impose specificity. Differential timing of expression can also prevent crosstalk. Another mechanism is the organization of signaling pathways by scaffold proteins. Scaffolds are proteins that interact with multiple 6 of 13
The Plant Cell members of a pathway and are thought to function as wiring elements that direct the flow of signaling information by tethering pathway components into complexes and localizing them to specific sites in the cell. Scaffolds are proposed to both enhance interactions between the correct signaling proteins and insulate them from interactions with competing proteins. One of the best studied examples of a signaling scaffold is the Ste5 (sterile-5) protein of yeasts, which plays an essential role in signal transmission through the mating pathway (Bhattacharyya et al., 2006) . Yeast MAPK kinase kinase (MAPKKK) Ste11 is a component of three distinct MAPK cascades that are involved in three different biological processes: mating, invasive growth, and high-osmolarity responses. Upon stimulation of a mating signal, a scaffold Ste5 forms a complex with Ste11, Ste7 (MAPKK), and Fus3 (MAPK) to prevent crosstalk with other MAPK cascades (Choi et al., 1994) . Furthermore, a domain of Ste5 acts as a substratespecific cocatalyst for Fus3 phosphorylation by Ste7 (Good et al., 2009 ), a role that is conceptually similar to that of a cyclin, which acts as a cocatalyst for the Cdk (Jeffrey et al., 1995; Ubersax and Ferrell, 2007) . The primary structures of CDPK isoforms are highly conserved, especially within their kinase domains. Scaffold proteins, such as Ste5, or targeting subunits, such as cyclin (Schulman et al., 1998) , which help to enhance substrate specificity, were not found for CDPKs. Thus, it was considered unlikely that CDPKs would have distinguishable substrate specificities. However, we showed that the specific repression of CDPK1 by RNA interference caused a marked reduction in Ser-114 kinase activity (Ishida et al., 2008) , suggesting a distinct physiological role of CDPK1 in tobacco plants. Loss-of-function mutations of Arabidopsis CDPKs CPK4 and CPK11 resulted in pleiotropic abscisic acid-insensitive phenotypes in Arabidopsis (Zhu et al., 2007) . Although the interaction between kinase and substrate was thought to be weak and transient, several studies showed that protein kinases form apparently stable complexes with transcription factors to facilitate signaling beyond the transient interaction between the enzyme and its substrate. Such examples include the binding of Hog1p (for high-osmolarity glycerol) to MAPKs in yeasts (Park et al., 2003) , PIAS1 to IKKa in mammalian cells (Liu et al., 2007) , and ERF7 to PKS3 in Arabidopsis (Song et al., 2005) . Previously, we showed that CDPK1 forms a complex with its substrate RSG in vivo (Ishida et al., 2008) . In this study, we found that a variable N-terminal domain of CDPK1 plays an essential role in the specific recognition of target RSG. (A) Feedback regulation of the GA 20-oxidase gene was suppressed in transgenic plants overexpressing CDPK1 but not in those overexpressing the R10A mutant version of CDPK1. Transgenic tobacco plants overexpressing CDPK1 or the R10A mutant version of CDPK1 under the control of the CaMV 35S promoter and control wild-type SR1 plants were grown with or without the GA biosynthesis inhibitor Uniconazole P for 1 week as indicated. The mRNA levels of GA 20-oxidase (GA20ox1) were examined by quantitative RT-PCR. After PCR, the products were detected by DNA gel blot hybridization. Tobacco arcA was amplified in the same reaction and used as an internal control for RT-PCR. The values at the bottom of the top panel indicate the relative level of strengths of signals after standardization using signals of arcA as a loading control. The value of SR1 without Uniconazole P was set to 1.0. Three transgenic lines were tested in at least three independent experiments with similar results. (B) Uniconazole P resistance was reduced in transgenic plants overexpressing CDPK1 but not in those overexpressing the R10A mutant version of CDPK1. Seeds of transgenic tobacco overexpressing CDPK1, transgenic tobacco overexpressing the R10A mutant version of CDPK1, and control wild-type SR1 plants were germinated in a medium containing 1 mM Uniconazole P with or without 1 mM GA 3 for 9 d at 288C. The values at the bottom of the panels indicate the germination ratio calculated from three independent plates (6SD, 80 to 100 seeds/plate). SR1, control wild-type SR1 tobacco plants; CDPKox, transgenic tobacco plants overexpressing CDPK1; R10Aox, transgenic tobacco plants overexpressing the R10A mutant version of CDPK1; +UniP, seedlings germinated on agarose containing Uniconazole P; +Uni+GA, seedlings germinated on agarose containing Uniconazole P and GA 3 .
Alteration of Substrate Specificity The Plant Cell
Since the R10A mutation in CDPK1 did not affect the catalytic activity of CDPK1 (Figure 3) , the variable N-terminal domain might function simply to increase the local concentration of the substrate around the kinase, differently from Ste5 and cyclins. If it is considered that the presence of a recognition domain positions a substrate within a 10-nm sphere of the kinase active site, then the effective concentration of the substrate would increase 3000-fold (Deshaies and Ferrell, 2001) ; this alone could be sufficient to greatly enhance the rate of phosphorylation of substrates that are present only in low amounts, including transcription factors. In addition, the variable N-terminal domain could induce a conformational change in RSG. The mutant versions of CDPK1 that do not bind to full-length RSG can phosphorylate the peptide of phosphorylation domain of RSG but not full-length RSG. Therefore, the interaction between fulllength RSG and the variable N-terminal domain of CDPK1 could result in an exposure of target site Ser-114 of RSG and help to orientate it correctly in the active site of CDPK1 through a conformational change in RSG.
The consensus phosphorylation site of CDPK is proposed to be basic-hydrophobic (f)-X-basic-X-X-Ser/Thr-X-X-X-f-basic (Harper and Harmon, 2005) . However, the presence of a consensus phosphorylation site in a protein does not guarantee that the protein is a substrate in vivo, and authentic phosphorylation sites do not always conform to the consensus (Ubersax and Ferrell, 2007) . The recognition by the variable N-terminal domain of CDPK1 may strictly determine the substrate specificity, in concert with the interaction between the kinase domain of CDPK1 and the phosphorylation site of the substrate. Among Ca 2+ binding sensory proteins in plants, CDPKs are thought to play central roles in Ca 2+ signaling. In Arabidopsis, CDPKs comprise a protein family with 34 members, all of which, except for CPK26, have a variable N-terminal domain consisting of 25 to 180 amino acids in length (see Supplemental Figure 2 
online).
Probably, the variable N-terminal domain of other CDPKs, as well as that of CDPK1, may be involved in substrate recognition. Yeast two-hybrid analysis suggested that the variable N-terminal domain of an Arabidopsis CDPK, CPK32, participates in the interaction with transcription factor ABF4 (Choi et al., 2005) . Although CDPKs have been reported to be involved in diverse physiological processes, very limited information is available about the direct substrates in vivo. The search for interacting proteins of the variable N-terminal domain by yeast two-hybrid screen or the TAP tag purification method would provide important clues to identify the physiological substrates of each CDPK. Such comprehensive studies would improve our understanding of both the physiological roles of each CDPK and the complicated network of Ca 2+ signaling in plants. The amino acid sequences of the variable N-terminal domain of CDPKs could have been selected during evolution both for the recognition of their true substrates and against the recognition of other potential substrates. Detailed analysis of specificity determinants in CDPKs, which greatly expanded in the plant kingdom, may help to reveal how cells coordinate multiple paralogous signaling pathways to maintain the information flow while preventing unwanted crosstalk.
We showed that CDPK1 binds to RSG in a Ca 2+ -dependent manner (Ishida et al., 2008) . In this study, we found that the variable N-terminal domain of CDPK1 is required for the interaction between CDPK1 and RSG (Figure 1) . The autoinhibitory domain between the kinase domain and the calmodulin-like domain serves to keep CDPK inactive in the resting state (Harmon et al., 1994) . Thus, a possible model for the functional regulation of RSG by GAs is as follows. GAs would increase the concentration of intracellular free Ca 2+ , which induces a conformational change of CDPK1 in response to Ca 2+ that allows the variable N-terminal domain to bind with RSG and the release of inhibition of kinase activity by the autoinhibitory domain. Then, (E) Feedback regulation of the GA 20-oxidase gene was suppressed in transgenic plants overexpressing the chimeric CDPK. Transgenic tobacco plants overexpressing At CPK9 or the chimeric CDPK under the control of the CaMV 35S promoter and control wild-type SR1 plants were grown with or without the GA biosynthesis inhibitor Uniconazole P for 1 week as indicated. The mRNA levels of GA 20-oxidase (GA20ox1) were examined by quantitative RT-PCR. After PCR, the products were detected by DNA gel blot hybridization. Tobacco arcA was amplified in the same reaction and used as an internal control for RT-PCR. The values at the bottom of the top panel indicate the relative level of strengths of signals after standardization using the signals of arcA as a loading control. The value of SR1 without Uniconazole P was set to 1.0. Three transgenic lines were tested in at least three independent experiments with similar results. (F) Uniconazole P resistance was reduced in transgenic plants overexpressing the chimeric CDPK. Seeds of transgenic tobacco overexpressing At CPK9 or the chimeric CDPK and control wild-type SR1 plants were germinated in a medium containing 1 mM Uniconazole P with or without 1 mM GA 3 for 9 d at 288C. The values at the bottom of panels indicate the germination ratio calculated from three independent plates (6SD, 80 to 100 seeds/plate). SR1, control wild-type SR1 tobacco plants; At CPK9ox, transgenic tobacco plants overexpressing At CPK9; Chimera ox, transgenic tobacco plants overexpressing the chimeric CDPK; +UniP, seedlings germinated on agarose containing Uniconazole P; +Uni+GA, seedlings germinated on agarose containing Uniconazole P and GA 3 .
Alteration of Substrate Specificity14-3-3 proteins bind to RSG depending on the RSG phosphorylation of Ser-114 by CDPK1 and thereby sequester RSG in the cytoplasm so that it is unable to regulate its target genes, including a GA biosynthetic gene, GA20ox1, in the nucleus. This mechanism may be a part of GA feedback regulation (Matsushita et al., 2007) . DELLA proteins are central players of GA signaling (reviewed in Fleet and Sun, 2005) . Upon GA perception, the degradation of nuclear DELLA proteins that are repressors of GA-dependent processes triggers GA signaling. One of the fastest known responses to GA is an increase in the concentration of cytosolic Ca 2+ (Bush, 1996) . Elucidation of the relationship between the degradation of DELLA and the activation of CDPK is an important subject for future investigation.
Another important finding of this study is that the variable N-terminal domain of Nt CDPK1 conferred sufficient RSG kinase activities to an Arabidopsis CDPK that only poorly phosphorylates RSG. Regions that help the substrate recognition, including SH2 and SH3 of Src (Ingley, 2008) , were found in several kinases (Loog and Morgan, 2005; Akella et al., 2008) , and, here, we report a modular domain that can alter substrate specificity. Our results also show that the substrate specificity of a protein kinase can be altered by manipulation of a region other than the kinase domain. Substitutions of amino acids near the active center might affect the substrate specificity but often simultaneously decrease the kinase activity (Gibbs and Zoller, 1991) . This is a major obstacle in the specificity engineering of kinases. Because the substrate recognition of CDPK is separable from the catalytic activity, CDPK may represent an excellent model system for the reprogramming of kinase-substrate relationship. Phylogenetic analyses have proposed that the CDPK gene family arose through the fusion of a CaMK and a calmodulin (Harper et al., 1991; Cheng et al., 2002) . The kinase domain of Nt CDPK1 is ;80% similar to that of mammalian CaMKs at the amino acid sequence level. The consensus phosphorylation site for CDPK is almost identical to that of CaMK (Songyang et al., 1996; Cheng et al., 2002) . Although CaMK has no variable N-terminal domain, addition of the variable N-terminal domain to a CaMK could provide a novel strategy for the alteration of kinase specificity in mammalian cells. Receptor kinases have been previously engineered and used in synthetic signaling circuits, but such studies have been limited to fusions of heterologous ligand binding domains to the cytoplasmic kinase domain (Utsumi et al., 1989; He et al., 2000) . There are only a few other studies in which the specificity of any kinase-substrate relationship has been completely redesigned in a rational way (Skerker et al., 2008) . Yeast scaffold proteins Ste5 and Pbs2 (for polymyxin B sensitivity) ensure the signaling specificity of the mating and high-osmolarity response MAPK pathways, respectively. A synthetic diverter scaffold that was constructed by fusing Ste5 and Pbs2 and mutagenically destroying interactions with the Ste7 and the upstream osmosensor Sho1 recruited the predicted non-native combination of kinases and created a synthetic MAPK pathway with non-natural inputoutput properties (Park et al., 2003) . Another remarkable example is the bacterial sensor His kinase EnvZ, which constitutes a two-component signal transduction system with response regulator OmpR. A few substitutions of amino acids in the His phosphotransfer domain of EnvZ switched the substrate specificity (Skerker et al., 2008) . In addition to the examples on unicellular organisms, we reported the change of the substrate specificity of a CDPK from higher plants. Taken together, these results indicate that specificity engineering of kinases is possible by different strategies, which may allow for rational rewiring of cellular signaling pathways.
METHODS

Plasmid Construction
Various deletion mutants of CDPK1 were constructed using PCR with plasmid harboring full-length Nt CDPK1 as a template and appropriate primers (see Supplemental Table 1 online). The amino acid substitution mutants of CDPK1 were generated by overlap extension PCR with the primers shown in Supplemental Table 1 online. In order to construct a chimeric CDPK in which the variable N-terminal domain of At CPK9 was substituted with that of Nt CDPK1, the cDNA fragments encoding Nt CDPK1 (1-94) and At CPK9 (91-345) were amplified by PCR with specific primers (see Supplemental Table 1 online) and cloned into pGEX-4T-1 (GE Healthcare).
For BiFC analysis, the DNA fragments corresponding to the N-terminal portion of a yellow fluorescence protein (YFP N ) and the C-terminal portion of a yellow fluorescence protein (YFP C ) were amplified by PCR with the pEYFP-Nuc vector (Clontech) as a template and the primers shown in Supplemental Table 1 online. The resultant products were cloned into pJ4 (Igarashi et al., 2001) , which were named pJ4YFP N or pJ4YFP C . Nt CDPK1 and RSG were amplified by PCR and cloned into pJ4YFP N and pJ4YFP C , respectively.
To generate transgenic tobacco plants overexpressing Nt CDPK1 or its mutant version Nt CDPK1(R10A), the DNA fragments were amplified using PCR with pGEX-4T-1 harboring wild-type CDPK1 or CDPK1(R10A) constructed above as a template and appropriate primers (see Supplemental Table 1 online) and cloned into pJ4 (Igarashi et al., 2001 ). The expression cassette was excised from the plasmid and inserted into pBI101.1 (Clontech).
To generate transgenic tobacco plants overexpressing both RSG-GFP and Nt CDPK1 or Nt CDPK1(R10A), the expression cassette of pJ4CDPK1 or pJ4CDPK1(R10A) was inserted to pPZP221 (Hajdukiewicz et al., 1994) . These plasmids were introduced into tobacco (Nicotiana tabacum) overexpressing RSG-GFP (Igarashi et al., 2001) .
To generate transgenic plants overexpressing TAP-tagged Nt CDPK1, At CPK9, or the chimeric CDPK, DNA constructs were prepared as follows: the cauliflower mosaic virus (CaMV) 35S promoter with a viral translation enhancer V and a nopaline synthase terminator (NOS terminator), attL1 and attL2, which are derived from pJ4 (Igarashi et al., 2001) , and pENTR1A (Invitrogen), were cloned into pUC18, which was named pMOE. attR1, attR2, and ccdB were inserted into pBI101.1, which was named pBI/attR. TAP tag was fused at the C terminus of each CDPK and cloned into pMOE. Cloned fragments were transferred to pBI/attR using Gateway LR Clonase (Invitrogen). These plasmids were introduced into tobacco SR1 via Agrobacterium tumefaciens (strain EHA105) leaf disc transformation using the standard transformation protocol (Curtis et al., 1995) .
Preparation of Protein Extracts
A total cell extract of young tobacco leaves was prepared as follows: leaves were disrupted in liquid nitrogen by grinding with a mortar and pestle and then extracted in 3 volumes of an extraction buffer (40 mM MOPS-NaOH, pH 6.5, 20 mM glycerol 2-phosphate disodium, 25mM NaCl, 10% glycerol, 0.1% Triton X-100, 0.05% b-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, a protease inhibitor cocktail [Pierce] , and a phosphatase inhibitor cocktail [Sigma-Aldrich] for the kinase assay or 10 of 13
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Immunoblot and Immunoprecipitation Analysis
Aliquots of each protein sample were resolved by SDS-PAGE (a Tris/ glycine buffer) and transferred onto a Immobilon-P transfer membrane (Millipore) and reacted with antiserum raised against the phosphorylated Ser-114 of RSG (anti-pS114; Ishida et al., 2004) , anti-Nt CDPK1 (Ishida et al., 2008) , anti-GFP (MBL), anti-GST (GE Healthcare), anti-MBP (MBL), or anti-FLAG (Rockland) followed by the horseradish peroxidase-conjugated second antibody. Chemiluminescence was detected (Immobilon Western Chemiluminescent HRP Substrate; Millipore) and quantified with a CCD camera imaging system (LAS-1000 plus; Fuji Film). Total protein was visualized by Coomassie Brilliant Blue staining for the loading control in some experiments. Aliquots of each protein sample were immunoprecipitated with anti-RSG (Igarashi et al., 2001 ) for 3 to 16 h at 48C, and then Protein G-conjugated beads (GE Healthcare) were added to each reaction. Immunoprecipitates were washed three times at 48C with wash buffer (40 mM MOPS-NaOH, pH 6.5, 20 mM glycerol 2-phosphate disodium, 25 mM NaCl, 0.1% Triton X-100, 0.05% b-mercaptoethanol, and 0.1 mM phenylmethylsulfonyl fluoride), and coprecipitated proteins were subjected to immunoblot analysis. Reactions without antibodies gave no signal.
In Vitro Kinase Assay
The catalytic activities of the purified various recombinant GST-CDPKs were assayed in a reaction mixture containing 20 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 0.5 mM CaCl 2 , 0.2 M NaCl, 0.1% Triton X-100, 10 mM b-mercaptoethanol, and 0.02 mg/mL MBP-RSG (full-length), 0.02 mg/mL MBP-RSG (70-140), or 0.4 mg/mL dephosphorylated casein as a substrate with 1 mM ATP (cold assay) or 1 mM ATP supplemented with [g-32 P]ATP (5000 mCi/mmol, 10 to 20 mCi/reaction, hot assay) at 308C for 10 to 30 min. Purified recombinant CDPKs (0.4 ng/mL) were used for the assay.
Reactions were subjected to SDS-PAGE (a Tris/glycine buffer) followed by immunoblot analysis for the cold assay or visualization of 32 Piphosphorylated polypeptides by the phosphor imager BAS 1800II (Fuji Film) for the hot assay.
In Vitro Binding Assay
Various purified recombinant GST-CDPKs (2.5 mg) and the recombinant full-length MBP-RSG (1.0 mg) and glutathione beads (GE Healthcare) were incubated in a binding buffer containing 25 mM MOPS-NaOH, pH 7.0, 100 mM NaCl, 0.05% b-mercaptoethanol, 0.1% Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, and 0.5 mM CaCl 2 at 48C for 60 min and washed with the binding buffer. Proteins binding to the beads were resolved by SDS-PAGE (a Tris/glycine buffer) and visualized by Coomassie Brilliant Blue staining or immunoblot analysis as described above.
BiFC Assay
For the expression of a set of YFP fusion proteins in tobacco, 500 mg of gold particles (1-mm diameter) were coated with 4 mg each of plasmid DNAs. The DNA-coated gold particles were spotted on macrocarriers and used to transform tobacco leaves at 1100 p.s.i. using a PDS-1000/He biolistic device (Bio-Rad Laboratories). After bombardment, leaves were incubated in a 50 mM phosphate buffer in darkness for 24 h at 288C, and the reconstituted YFP fluorescence signals were then investigated using an epifluorescence microscope ECLIPSE 80i (Nikon) with the YFP filter (500/20 nm excitation, 535/30 nm emission). Images were captured with a CCD camera and exported as TIFF format files and further processed with bit map-based image editing software.
RT-PCR
The effects of Uniconazole P, an inhibitor of GA biosynthesis (Wako), on the gene expression were examined by RT-PCR using plants grown in soil individually in 0.5-liter beakers as described previously (Ishida et al., 2004) . Young plants (N. tabacum cv Petite Havana SR1) received 150 mL of 34 mM Uniconazole P twice a week.
For quantitative RT-PCR studies, total RNAs from the stem of transgenic tobacco expressing various CDPKs under the control of the CaMV 35S promoter or control wild-type SR1 were converted into cDNA with ReverTra Ace (TOYOBO) and oligo(dT) [12] [13] [14] [15] [16] [17] [18] . PCR was performed with cDNA derived from 0.5 mg of total RNA with ExTaq (TaKaRa). The primer sequences for GA20ox1 and tobacco arcA (Ishida et al., 1993) , an internal control for RT-PCR, are shown in Supplemental Table 1 online. The PCR was run for 18, 21, and 24 cycles at 948C for 30 s, 538C for 30 s, and 728C for 30 s to ensure that amplifications were within the linear range. The PCR products were size separated on a 1% (w/v) agarose gel, blotted onto Hybond-N + (GE Healthcare), and hybridized with digoxigenin (DIG)-labeled gene-specific DNA probes. After overnight hybridization, blots were washed, and the DIG-labeled probes were then detected with Anti-DIG-Alkaline Phosphatase (Roche) and CDPstar (Roche) using a CCD camera imaging system (LAS-1000 plus; Fuji Film).
Uniconazole P Tolerance Assay
Seeds of transgenic tobacco expressing various CDPKs under the control of the CaMV 35S promoter or control wild-type SR1 were germinated on half-strength Murashige and Skoog medium containing 0.8% agar and 1 mM Uniconazole P (Wako) with or without 1 mM GA 3 for 9 d at 288C. Plates were photographed with a digital camera, and images were exported and further processed as described above.
Accession Numbers
Sequence data from this article can be found in the Arabidopsis Genome Initiative or GenBank/EMBL databases under the following accession numbers: AB040471 (RSG), AF072908 (Nt CDPK1), U31751(At CPK9, AT3G20410), AB012856 (Nt GA20ox1), and D17526 (arcA).
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